Early Access — free while we kick the tires
EdgarHawk

Giordano Christopher Thomas

CEO

Director Officer
1 filing analyzed · 1 company · Latest 2025-11-20

Companies

Company Buys Sells Direction
TENAX THERAPEUTICS, INC. TENX 3 0 Net buying

Activity

November 2025
high
Buy
2,605 shares
$20,000
Significance 7/10

CEO Giordano Thomas buys 2,605 shares for $19,999.78 across 3 transactions; cluster pattern with 2 other insiders buying within 14 days.

CEO Giordano Thomas purchased 2,605 shares across three separate transactions at an average price of $7.68 per share between November 18–20, 2025, with the stock currently trading at $7.70. This filing reflects a cluster buy pattern, with 2 other insiders also purchasing shares within the past 14 days, suggesting coordinated or near-simultaneous confidence at current price levels. Notably, the company is unprofitable with net income of $-15.8M over its most recent full fiscal year and zero revenue in the latest quarter, yet the stock has appreciated 28.3% over the past 90 days and 6.6% over the past 30 days. The CEO's establishment of an initial 2.6K share position may warrant scrutiny given the fundamental profile, though the clustering of insider purchases across multiple executives deserves investor attention.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access